Michael Barbella, Managing Editor03.19.22
Reprocessed medical devices and digital health took top billing with website visitors this past week, as both GE Healthcare and Philips capitalized on the Healthcare Information and Management Systems Society's (HIMSS) 2022 annual meeting to debut new products and services.
Philips announced the expansion of its medical device cybersecurity services portfolio at HIMSS22 by introducing Secure Remote Access Management Service. The Service leverages a broad set of security capabilities—enabled by the integration of SecureLink's critical access management and governance technology—with Philips Remote Services' secure connectivity framework for technical and clinical support. The services provide benefits for healthcare providers including increased uptime, clinical performance, and advanced security to help protect access to their clinical solutions and medical devices.
At the same meeting, GE Healthcare unveiled its Edison Digital Health Platform, a vendor-agnostic hosting and data aggregation platform with an artificial intelligence (AI) engine. The platform aims to deploy clinical, workflow, analytics, and AI tools to support improved care delivery, high-efficiency operations, and increase revenue growth. Edison Digital Health accelerates app integration via connecting devices and other sources of data into an aggregated clinical data layer. The platform offers data transformation tools to support analytics and enable AI model training and deployment using the aggregated data.
In addition to its device cybersecurity expansion, Philips also made headlines this past week with the FDA 510(k) clearance of the latest Philips Capsule Surveillance solution. Capable of utilizing streaming data from virtually any connected medical device, the solution aggregates patient data, analyzes it to generate actionable insights and alerts, and sends timely notifications to the patient’s caregivers so that they can intervene before deterioration progresses further.
The week's top traffic driver, however, was neither Philips nor GE Healthcare, but Coherent Market Insights' rosy forecast for the the global reprocessed medical devices market. Operational savings measures at hospitals and increasing demand for such products is expected to facilitate a 20.4 percent compound annual growth rate for the market through the start of 2028.
1. Reprocessed Medical Devices Market to Gain Popularity This Decade
2. Dexcom G7 CGM Earns EU Approval
3. Philips Capsule Surveillance Solution Cleared by FDA
4. Royal Philips Expands Medical Device Cybersecurity Portfolio at HIMSS22
Philips announced the expansion of its medical device cybersecurity services portfolio at HIMSS22 by introducing Secure Remote Access Management Service. The Service leverages a broad set of security capabilities—enabled by the integration of SecureLink's critical access management and governance technology—with Philips Remote Services' secure connectivity framework for technical and clinical support. The services provide benefits for healthcare providers including increased uptime, clinical performance, and advanced security to help protect access to their clinical solutions and medical devices.
At the same meeting, GE Healthcare unveiled its Edison Digital Health Platform, a vendor-agnostic hosting and data aggregation platform with an artificial intelligence (AI) engine. The platform aims to deploy clinical, workflow, analytics, and AI tools to support improved care delivery, high-efficiency operations, and increase revenue growth. Edison Digital Health accelerates app integration via connecting devices and other sources of data into an aggregated clinical data layer. The platform offers data transformation tools to support analytics and enable AI model training and deployment using the aggregated data.
In addition to its device cybersecurity expansion, Philips also made headlines this past week with the FDA 510(k) clearance of the latest Philips Capsule Surveillance solution. Capable of utilizing streaming data from virtually any connected medical device, the solution aggregates patient data, analyzes it to generate actionable insights and alerts, and sends timely notifications to the patient’s caregivers so that they can intervene before deterioration progresses further.
The week's top traffic driver, however, was neither Philips nor GE Healthcare, but Coherent Market Insights' rosy forecast for the the global reprocessed medical devices market. Operational savings measures at hospitals and increasing demand for such products is expected to facilitate a 20.4 percent compound annual growth rate for the market through the start of 2028.